Theranos Relents, Will Publish Blood Test Data

Medical testing startup Theranos has agreed to publish data that it says will validate the accuracy of its blood tests after they were called into question by a Wall Street Journal article published last week.

Elizabeth Holmes, the billionaire CEO of the rapidly growing company, confirmed that Theranos would make the information public in a bid to quell attacks claiming the company wasn’t using its own technology in its tests. “Data is a powerful thing because it speaks for itself,” she said, speaking at a conference sponsored by the Cleveland Clinic on Monday night. Holmes did not say when or where her company would actually make the information public.

Read the rest of this post on the original site »

This article originally appeared on Recode.net.

Will you join us?

Our biggest supporters are our readers — and we’re so grateful to everyone who has made a contribution during our September campaign. We’re less than 1,000 contributions away from reaching our goal for the month, which in turn will allow us to say yes more often when our incredible journalists come to us with questions they want to answer and projects they want to pursue. Will you make a contribution before the month ends and support our policy coverage through 2024 and beyond?

One-Time Monthly Annual

$5/month

$10/month

$25/month

$50/month

Other

$

Yes, I'll give $5/month

Yes, I'll give $5/month

We accept credit card, Apple Pay, and Google Pay. You can also contribute via